Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03046771 · ClinicalTrials.gov registry record · NA
Transport PLUS Intervention
A NA study of Fall and Hospital Readmission, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT03046771: Completed NA study of Fall and Hospital Readmission, sponsored by Icahn School of Medicine at Mount Sinai.
NCT03046771 is a NA study of Fall and Hospital Readmission that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 58 participants, below the 1,305-participant average among 19 other Fall trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03046771, a NA study of Fall and Hospital Readmission, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothesis: 'Transport PLUS,' a low cost, easily generalizable intervention performed by Emergency Medical Technicians while transporting a patient home from the hospital, can improve transitions of care and improve patient safety following hospitalization as measured by decreased rates of falls and reduced rates of return to the hospital.
Primary Outcome
Rate of falls following transport home by ambulance
Conditions Studied
Interventions
- BEHAVIORAL Transport PLUS group
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2017-01-19 |
| Est. Completion | 2019-05-30 |
| Phase | NA |
What the finished NCT03046771 record still lists
NCT03046771 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,305-participant average among 19 other Fall trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Fall appearing as the primary indexed condition, and to 1 intervention - of which Transport PLUS group is the first listed.
NCT03046771 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03046771 about?
NCT03046771 is a clinical study titled "Transport PLUS Intervention". Hypothesis: 'Transport PLUS,' a low cost, easily generalizable intervention performed by Emergency Medical Technicians while transporting a patient home from the hospital, can improve transitions of care and improve patient safety following hospitalization as measured by decreased rates of falls and...
What is the current status of trial NCT03046771?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2017-01-19. Estimated completion is 2019-05-30.
What conditions does trial NCT03046771 study?
This clinical trial studies the following conditions: Fall, Hospital Readmission, Emergency Medical Services, Fall, Accidental.
What interventions are being tested in trial NCT03046771?
The interventions under investigation include: Transport PLUS group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03046771?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03046771 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fall
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03046771's enrollment target sits among peer trials
58 10th of 19 higher than 10 of 19 other Fall trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fall trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
RECRUITING · NA
-
Optimizing a Technology-based Body and Mind Intervention
RECRUITING · NA
-
Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults
RECRUITING · NA
-
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
RECRUITING · NA
-
Real-life Dual-Task Training
RECRUITING · NA
-
Exercise Program for Deaf Seniors to Increase Their Balance and Fitness
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI